Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Patterning | 5 | 2016 | 44 | 1.190 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2019 | 44 | 1.100 |
Why?
|
| Mammary Glands, Animal | 2 | 2016 | 71 | 0.990 |
Why?
|
| Xenopus Proteins | 5 | 2011 | 31 | 0.630 |
Why?
|
| Activin Receptors | 4 | 2006 | 9 | 0.620 |
Why?
|
| Neovascularization, Pathologic | 1 | 2019 | 183 | 0.610 |
Why?
|
| Mesoderm | 4 | 2006 | 231 | 0.580 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2016 | 18 | 0.570 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 307 | 0.560 |
Why?
|
| Organogenesis | 1 | 2016 | 49 | 0.550 |
Why?
|
| Situs Inversus | 2 | 2006 | 13 | 0.530 |
Why?
|
| Fetal Heart | 2 | 2006 | 41 | 0.530 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2014 | 8 | 0.470 |
Why?
|
| Genes, erbB-2 | 1 | 2014 | 15 | 0.470 |
Why?
|
| Epithelium | 1 | 2014 | 172 | 0.460 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 74 | 0.450 |
Why?
|
| Heart Defects, Congenital | 2 | 2006 | 596 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1536 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2006 | 328 | 0.330 |
Why?
|
| Xenopus | 2 | 2006 | 30 | 0.330 |
Why?
|
| Heart | 3 | 2011 | 850 | 0.320 |
Why?
|
| Cell Lineage | 2 | 2006 | 146 | 0.320 |
Why?
|
| Endocardial Cushion Defects | 1 | 2005 | 11 | 0.270 |
Why?
|
| Activin Receptors, Type I | 4 | 2006 | 14 | 0.260 |
Why?
|
| Xenopus laevis | 4 | 2011 | 60 | 0.250 |
Why?
|
| Functional Laterality | 1 | 2006 | 240 | 0.250 |
Why?
|
| Animals | 10 | 2019 | 20881 | 0.230 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 442 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 384 | 0.190 |
Why?
|
| Mice | 3 | 2019 | 8474 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 2 | 2011 | 64 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 306 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 213 | 0.150 |
Why?
|
| Homeodomain Proteins | 3 | 2011 | 157 | 0.140 |
Why?
|
| In Situ Hybridization | 2 | 2006 | 201 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2011 | 1034 | 0.120 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1851 | 0.120 |
Why?
|
| Female | 5 | 2019 | 38074 | 0.110 |
Why?
|
| Lithium | 1 | 2011 | 76 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2550 | 0.100 |
Why?
|
| Larva | 1 | 2011 | 39 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2005 | 1664 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2011 | 57 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 689 | 0.090 |
Why?
|
| Blastula | 2 | 2011 | 4 | 0.090 |
Why?
|
| Stem Cells | 1 | 2011 | 248 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 710 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 337 | 0.060 |
Why?
|
| Tail | 1 | 2005 | 8 | 0.060 |
Why?
|
| Gastrula | 1 | 2005 | 17 | 0.060 |
Why?
|
| Myocardium | 1 | 2011 | 1204 | 0.060 |
Why?
|
| Neural Crest | 1 | 2005 | 58 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2005 | 56 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 317 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2004 | 238 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2011 | 2689 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2004 | 753 | 0.040 |
Why?
|
| Humans | 3 | 2019 | 68618 | 0.040 |
Why?
|
| Time Factors | 1 | 2005 | 4655 | 0.030 |
Why?
|
| Gastrulation | 1 | 2011 | 4 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Maleimides | 1 | 2011 | 15 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2011 | 32 | 0.020 |
Why?
|
| Aminophenols | 1 | 2011 | 19 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 49 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2011 | 49 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 62 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 770 | 0.020 |
Why?
|